Lentine KL, Segev DL: Understanding and communicating Medical risks for living kidney donors: A matter of perspective. J Am Soc Nephrol28: 12–24, 2017PubMed
3
LamNN, LentineKL, LeveyAS, KasiskeBL, GargAX: Long-term medical risks to the living kidney donor. Nat Rev Nephrol11: 411–419, 2015PubMed
LamNN, LentineKL, LeveyAS, KasiskeBL, GargAX: Long-term medical risks to the living kidney donor. Nat Rev Nephrol 11: 411–419, 2015PubMed)| false
LentineKL, LamNN, SegevDL: Risks of living kidney donation: Current state of knowledge on outcomes important to donors. Clin J Am Soc Nephrol14: 597–608, 2019PubMed
LentineKL, LamNN, SegevDL: Risks of living kidney donation: Current state of knowledge on outcomes important to donors. Clin J Am Soc Nephrol 14: 597–608, 2019PubMed)| false
GargAX, PougetJ, YoungA, HuangA, BoudvilleN, HodsmanA, et al.; Donor Nephrectomy Outcomes Research (DONOR) Network: Fracture risk in living kidney donors: A matched cohort study. Am J Kidney Dis59: 770–776, 2012PubMed
GargAX, PougetJ, YoungA, HuangA, BoudvilleN, HodsmanA, ; Donor Nephrectomy Outcomes Research (DONOR) Network: Fracture risk in living kidney donors: A matched cohort study. Am J Kidney Dis 59: 770–776, 2012PubMed)| false
ThomasSM, LamNN, WelkBK, NguanC, HuangA, NashDM, et al.; Donor Nephrectomy Outcomes Research (DONOR) Network: Risk of kidney stones with surgical intervention in living kidney donors. Am J Transplant13: 2935–2944, 2013PubMed
ThomasSM, LamNN, WelkBK, NguanC, HuangA, NashDM, ; Donor Nephrectomy Outcomes Research (DONOR) Network: Risk of kidney stones with surgical intervention in living kidney donors. Am J Transplant 13: 2935–2944, 2013PubMed)| false
LamNN, McArthurE, KimSJ, PrasadGV, LentineKL, ReesePP, et al.; Donor Nephrectomy Outcomes Research (DONOR) Network; Donor Nephrectomy Outcomes Research DONOR Network: Gout after living kidney donation: A matched cohort study. Am J Kidney Dis65: 925–932, 2015PubMed
LamNN, McArthurE, KimSJ, PrasadGV, LentineKL, ReesePP, ; Donor Nephrectomy Outcomes Research (DONOR) Network; Donor Nephrectomy Outcomes Research DONOR Network: Gout after living kidney donation: A matched cohort study. Am J Kidney Dis 65: 925–932, 2015PubMed)| false
SegevDL, MuzaaleAD, CaffoBS, MehtaSH, SingerAL, TarantoSE, et al.: Perioperative mortality and long-term survival following live kidney donation. JAMA303: 959–966, 2010PubMed
SegevDL, MuzaaleAD, CaffoBS, MehtaSH, SingerAL, TarantoSE, : Perioperative mortality and long-term survival following live kidney donation. JAMA 303: 959–966, 2010PubMed)| false
GargN, LentineKL, InkerLA, GargAX, RodrigueJR, SegevDL, et al.: Metabolic, cardiovascular, and substance use evaluation of living kidney donor candidates: US practices in 2017. Am J Transplant20: 3390–3400, 2020PubMed
GargN, LentineKL, InkerLA, GargAX, RodrigueJR, SegevDL, : Metabolic, cardiovascular, and substance use evaluation of living kidney donor candidates: US practices in 2017. Am J Transplant 20: 3390–3400, 2020PubMed)| false
GargN, LentineKL, InkerLA, GargAX, RodrigueJR, SegevDL, et al.: The kidney evaluation of living kidney donor candidates: US practices in 2017. Am J Transplant20: 3379–3389, 2020PubMed
GargN, LentineKL, InkerLA, GargAX, RodrigueJR, SegevDL, : The kidney evaluation of living kidney donor candidates: US practices in 2017. Am J Transplant 20: 3379–3389, 2020PubMed)| false
LentineKL, KasiskeBL, LeveyAS, AdamsPL, AlberúJ, BakrMA, et al.: KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation101: S1–S109, 2017PubMed
LentineKL, KasiskeBL, LeveyAS, AdamsPL, AlberúJ, BakrMA, : KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation 101: S1–S109, 2017PubMed)| false
Organ Procurement and Transplantation Network (OPTN)/United Network for Organ Sharing (UNOS): OPTN Policies, Policy 14: Living Donation. Available at: http://optn.transplant.hrsa.gov/governance/policies/. Accessed August 7, 2022
19
DoshiMD, TalerSJ: Evaluation of Hypertension in Living Donor Candidates. In: Living Kidney Donation, edited by Lentine, KL, Concepcion BP, Lerma EV, Cham, Springer, 2021, pp 1199–139
DoshiMD, TalerSJ: Evaluation of Hypertension in Living Donor Candidates. In: Living Kidney Donation, edited by Lentine, KL, Concepcion BP, Lerma EV, Cham, Springer, 2021, pp 1199–139)| false
ChobanianAV, BakrisGL, BlackHR, CushmanWC, GreenLA, IzzoJLJr, et al.; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA289: 2560–2572, 2003PubMed
ChobanianAV, BakrisGL, BlackHR, CushmanWC, GreenLA, IzzoJLJr, ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 289: 2560–2572, 2003PubMed)| false
WheltonPK, CareyRM, AronowWS, CaseyDEJr, CollinsKJ, Dennison HimmelfarbC, et al.: 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension71: 1269–1324, 2018PubMed
WheltonPK, CareyRM, AronowWS, CaseyDEJr, CollinsKJ, Dennison HimmelfarbC, : 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 71: 1269–1324, 2018PubMed)| false
MerzkaniMA, MullanA, DenicA, D’CostaM, IversonR, KremersW, et al.: Renal function outcomes and kidney biopsy features of living kidney donors with hypertension. Clin Transplant35: e14293, 2021PubMed
MerzkaniMA, MullanA, DenicA, D’CostaM, IversonR, KremersW, : Renal function outcomes and kidney biopsy features of living kidney donors with hypertension. Clin Transplant 35: e14293, 2021PubMed)| false
Al AmmaryF, LuoX, MuzaaleAD, MassieAB, CrewsDC, WaldramMM, et al.: Risk of ESKD in older live kidney donors with hypertension. Clin J Am Soc Nephrol14: 1048–1055, 2019PubMed
Al AmmaryF, LuoX, MuzaaleAD, MassieAB, CrewsDC, WaldramMM, : Risk of ESKD in older live kidney donors with hypertension. Clin J Am Soc Nephrol 14: 1048–1055, 2019PubMed)| false
ChaudryM, GislasonGH, FosbølEL, KøberL, GerdsTA, Torp-PedersenC: Hypertension, cardiovascular disease and cause of death in Danish living kidney donors: matched cohort study. BMJ Open10: e041122, 2020PubMed
ChaudryM, GislasonGH, FosbølEL, KøberL, GerdsTA, Torp-PedersenC: Hypertension, cardiovascular disease and cause of death in Danish living kidney donors: matched cohort study. BMJ Open 10: e041122, 2020PubMed)| false
HolscherCM, HaugenCE, JacksonKR, Garonzik WangJM, WaldramMM, BaeS, et al.: Self-reported incident hypertension and long-term kidney function in living kidney donors compared with healthy nondonors. Clin J Am Soc Nephrol14: 1493–1499, 2019PubMed
HolscherCM, HaugenCE, JacksonKR, Garonzik WangJM, WaldramMM, BaeS, : Self-reported incident hypertension and long-term kidney function in living kidney donors compared with healthy nondonors. Clin J Am Soc Nephrol 14: 1493–1499, 2019PubMed)| false
Naik AS, Cibrik DM, Sakhuja A, et al.: Temporal trends, center-level variation, and the impact of prevalent state obesity rates on acceptance of obese living kidney donors. Am J Transplant18: 642–649, 2018 PubMed
28
Grams ME, Sang Y, Levey AS, Matsushita K, Ballew S, Chang AR, et al.: Kidney-failure risk projection for the living kidney-donor candidate. N Engl J Med374: 411–421, 2016 PubMed
29
MuzaaleAD, MassieAB, WangMC, MontgomeryRA, McBrideMA, WainrightJL, et al.: Risk of end-stage renal disease following live kidney donation. JAMA311: 579–586, 2014PubMed
MuzaaleAD, MassieAB, WangMC, MontgomeryRA, McBrideMA, WainrightJL, : Risk of end-stage renal disease following live kidney donation. JAMA 311: 579–586, 2014PubMed)| false
LockeJE, ReedRD, MassieAB, MacLennanPA, SawinskiD, KumarV, et al.: Obesity and long-term mortality risk among living kidney donors. Surgery166: 205–208, 2019PubMed
LockeJE, ReedRD, MassieAB, MacLennanPA, SawinskiD, KumarV, : Obesity and long-term mortality risk among living kidney donors. Surgery 166: 205–208, 2019PubMed)| false
LockeJE, ReedRD, MassieA, MacLennanPA, SawinskiD, KumarV, et al.: Obesity increases the risk of end-stage renal disease among living kidney donors. Kidney Int91: 699–703, 2017PubMed
LockeJE, ReedRD, MassieA, MacLennanPA, SawinskiD, KumarV, : Obesity increases the risk of end-stage renal disease among living kidney donors. Kidney Int 91: 699–703, 2017PubMed)| false
PekGXW, NgohCLY, TeoBW, VathsalaA, GohBYS, YongCHR, et al.: Visceral obesity in Asian living kidney donors significantly impacts early renal function after donor nephrectomy. World J Urol37: 2231–2234, 2019PubMed
PekGXW, NgohCLY, TeoBW, VathsalaA, GohBYS, YongCHR, : Visceral obesity in Asian living kidney donors significantly impacts early renal function after donor nephrectomy. World J Urol 37: 2231–2234, 2019PubMed)| false
ChakkeraHA, ChangYH, ThomasLF, AvulaRT, AmerH, LermanLO, et al.: Obesity correlates with glomerulomegaly but is not associated with kidney dysfunction early after donation. Transplant Direct1: 1–6, 2015PubMed
ChakkeraHA, ChangYH, ThomasLF, AvulaRT, AmerH, LermanLO, : Obesity correlates with glomerulomegaly but is not associated with kidney dysfunction early after donation. Transplant Direct 1: 1–6, 2015PubMed)| false
LentineKL, KoraishyFM, SarabuN, NaikAS, LamNN, GargAX, et al.: Associations of obesity with antidiabetic medication use after living kidney donation: An analysis of linked national registry and pharmacy fill records. Clin Transplant33: e13696, 2019PubMed
LentineKL, KoraishyFM, SarabuN, NaikAS, LamNN, GargAX, : Associations of obesity with antidiabetic medication use after living kidney donation: An analysis of linked national registry and pharmacy fill records. Clin Transplant 33: e13696, 2019PubMed)| false
HuangN, FosterMC, LentineKL, GargAX, PoggioED, KasiskeBL, et al.: Estimated GFR for living kidney donor evaluation. Am J Transplant16: 171–180, 2016PubMed
HuangN, FosterMC, LentineKL, GargAX, PoggioED, KasiskeBL, : Estimated GFR for living kidney donor evaluation. Am J Transplant 16: 171–180, 2016PubMed)| false
GargAX, LeveyAS, KasiskeBL, CheungM, LentineKL; KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors Work Group and Evidence Review Team: Application of the 2017 KDIGO Guideline for the Evaluation and Care of Living Kidney Donors to Clinical Practice. Clin J Am Soc Nephrol15: 896–905, 2020PubMed
GargAX, LeveyAS, KasiskeBL, CheungM, LentineKL; KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors Work Group and Evidence Review Team: Application of the 2017 KDIGO Guideline for the Evaluation and Care of Living Kidney Donors to Clinical Practice. Clin J Am Soc Nephrol 15: 896–905, 2020PubMed)| false
LentineKL, LeveyAS, SegevDL: Integrated risk assessment versus age-specific GFR thresholds for living donor candidate evaluation. Transplantation104: 2464–2466, 2020PubMed
LentineKL, LeveyAS, SegevDL: Integrated risk assessment versus age-specific GFR thresholds for living donor candidate evaluation. Transplantation 104: 2464–2466, 2020PubMed)| false
DoshiMD, SinghN, HippenBE, WoodsideKJ, MohanP, ByfordHL, et al.: Transplant clinician opinions on use of race in the estimation of glomerular filtration rate. Clin J Am Soc Nephrol16: 1552–1559, 2021PubMed
DoshiMD, SinghN, HippenBE, WoodsideKJ, MohanP, ByfordHL, : Transplant clinician opinions on use of race in the estimation of glomerular filtration rate. Clin J Am Soc Nephrol 16: 1552–1559, 2021PubMed)| false
DelgadoC, BawejaM, CrewsDC, EneanyaND, GadegbekuCA, InkerLA, et al.: A unifying approach for GFR estimation: Recommendations of the NKF-ASN Task Force on reassessing the inclusion of race in diagnosing kidney disease. J Am Soc Nephrol79: 268–288.e1, 2022PubMed
DelgadoC, BawejaM, CrewsDC, EneanyaND, GadegbekuCA, InkerLA, : A unifying approach for GFR estimation: Recommendations of the NKF-ASN Task Force on reassessing the inclusion of race in diagnosing kidney disease. J Am Soc Nephrol 79: 268–288.e1, 2022PubMed)| false
DelgadoC, BawejaM, BurrowsNR, CrewsDC, EneanyaND, GadegbekuCA, et al.: Reassessing the inclusion of race in diagnosing kidney diseases: An interim report from the NKF-ASN Task Force. J Am Soc Nephrol32: 1305–1317, 2021PubMed
DelgadoC, BawejaM, BurrowsNR, CrewsDC, EneanyaND, GadegbekuCA, : Reassessing the inclusion of race in diagnosing kidney diseases: An interim report from the NKF-ASN Task Force. J Am Soc Nephrol 32: 1305–1317, 2021PubMed)| false
GargN, SnyderG, LiJ, MandelbrotD, PoggioED: Performance of creatinine clearance and estimated GFR in assessing kidney function in living donor candidates. Transplantation104: 575–582, 2020PubMed
GargN, SnyderG, LiJ, MandelbrotD, PoggioED: Performance of creatinine clearance and estimated GFR in assessing kidney function in living donor candidates. Transplantation 104: 575–582, 2020PubMed)| false
MontgomeryJR, BrownCS, ZondlakAN, WalshKW, KozlowskiJE, PinskyAM, et al.: CT-measured cortical volume ratio is an accurate alternative to nuclear medicine split scan ratio among living kidney donors. Transplantation105: 2596–2605, 2021PubMed
MontgomeryJR, BrownCS, ZondlakAN, WalshKW, KozlowskiJE, PinskyAM, : CT-measured cortical volume ratio is an accurate alternative to nuclear medicine split scan ratio among living kidney donors. Transplantation 105: 2596–2605, 2021PubMed)| false
Poggio ED, Khan N, Bolanos C, Pham T, Tan JC: Evaluation of renal anatomy, structure and nephrolithiasis in living donor candidates. In: Living Kidney Donation, edited by Lentine KL, Concepcion BP, Lerma EV, Cham, Springer, 2021, pp 93–117
50
FerraroPM, CurhanGC, D’AddessiA, GambaroG: Risk of recurrence of idiopathic calcium kidney stones: Analysis of data from the literature. J Nephrol30: 227–233, 2017PubMed
FerraroPM, CurhanGC, D’AddessiA, GambaroG: Risk of recurrence of idiopathic calcium kidney stones: Analysis of data from the literature. J Nephrol 30: 227–233, 2017PubMed)| false
ThomasCP, MansillaMA, SompallaeR, MasonSO, NishimuraCJ, KimbleMJ, et al.: Screening of living kidney donors for genetic diseases using a comprehensive genetic testing strategy. Am J Transplant17: 401–410, 2017PubMed
ThomasCP, MansillaMA, SompallaeR, MasonSO, NishimuraCJ, KimbleMJ, : Screening of living kidney donors for genetic diseases using a comprehensive genetic testing strategy. Am J Transplant 17: 401–410, 2017PubMed)| false
CaliskanY, LentineKL: Approach to genetic testing to optimize the safety of living donor transplantation in alport syndrome spectrum. Pediatr Nephrol37: 1981–1994, 2022 35088158
CaliskanY, LentineKL: Approach to genetic testing to optimize the safety of living donor transplantation in alport syndrome spectrum. Pediatr Nephrol 37: 1981–1994, 2022 35088158)| false
CaliskanY, LeeB, WhelanAM, AbualrubF, LentineKL, JittiratA: Evaluation of genetic kidney diseases in living donor kidney transplantation: Towards precision genomic medicine in donor risk assessment. Curr Transpl Rep9: 127–142, 2022
CaliskanY, LeeB, WhelanAM, AbualrubF, LentineKL, JittiratA: Evaluation of genetic kidney diseases in living donor kidney transplantation: Towards precision genomic medicine in donor risk assessment. Curr Transpl Rep 9: 127–142, 2022)| false
LentineKL, MannonRB: Apolipoprotein L1: Role in the evaluation of kidney transplant donors. Curr Opin Nephrol Hypertens29: 645–655, 2020PubMed
LentineKL, MannonRB: Apolipoprotein L1: Role in the evaluation of kidney transplant donors. Curr Opin Nephrol Hypertens 29: 645–655, 2020PubMed)| false
GenoveseG, FriedmanDJ, RossMD, LecordierL, UzureauP, FreedmanBI, et al.: Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science329: 841–845, 2010PubMed
GenoveseG, FriedmanDJ, RossMD, LecordierL, UzureauP, FreedmanBI, : Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329: 841–845, 2010PubMed)| false
TzurS, RossetS, ShemerR, YudkovskyG, SeligS, TarekegnA, et al.: Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet128: 345–350, 2010PubMed
TzurS, RossetS, ShemerR, YudkovskyG, SeligS, TarekegnA, : Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet 128: 345–350, 2010PubMed)| false
ChaudharyNS, MooreJX, ZakaiNA, JuddSE, NaikRP, LimouS, et al.: APOL1 nephropathy risk alleles and risk of sepsis in blacks. Clin J Am Soc Nephrol14: 1733–1740, 2019PubMed
ChaudharyNS, MooreJX, ZakaiNA, JuddSE, NaikRP, LimouS, : APOL1 nephropathy risk alleles and risk of sepsis in blacks. Clin J Am Soc Nephrol 14: 1733–1740, 2019PubMed)| false
DiversJ, MaL, BrownWM, PalmerND, ChoiY, IsraniAK, et al.: Genome-wide association studies for time to failure of kidney transplants from African American deceased donors. Clin Transplant34: e13827, 2020PubMed
DiversJ, MaL, BrownWM, PalmerND, ChoiY, IsraniAK, : Genome-wide association studies for time to failure of kidney transplants from African American deceased donors. Clin Transplant 34: e13827, 2020PubMed)| false
LockeJE, SawinskiD, ReedRD, SheltonB, MacLennanPA, KumarV, et al.: Apolipoprotein L1 and chronic kidney disease risk in young potential living kidney donors. Ann Surg267: 1161–1168, 2018PubMed
LockeJE, SawinskiD, ReedRD, SheltonB, MacLennanPA, KumarV, : Apolipoprotein L1 and chronic kidney disease risk in young potential living kidney donors. Ann Surg 267: 1161–1168, 2018PubMed)| false
DoshiMD, Ortigosa-GogginsM, GargAX, LiL, PoggioED, WinklerCA, et al.: APOL1 genotype and renal function of black living donors. J Am Soc Nephrol29: 1309–1316, 2018PubMed
DoshiMD, Ortigosa-GogginsM, GargAX, LiL, PoggioED, WinklerCA, : APOL1 genotype and renal function of black living donors. J Am Soc Nephrol 29: 1309–1316, 2018PubMed)| false
Fehrman-EkholmI, NordénG, LennerlingA, RizellM, MjörnstedtL, WramnerL, et al.: Incidence of end-stage renal disease among live kidney donors. Transplantation82: 1646–1648, 2006PubMed
Fehrman-EkholmI, NordénG, LennerlingA, RizellM, MjörnstedtL, WramnerL, : Incidence of end-stage renal disease among live kidney donors. Transplantation 82: 1646–1648, 2006PubMed)| false
LamNN, LentineKL, GargAX: End-stage renal disease risk in live kidney donors: What have we learned from two recent studies?Curr Opin Nephrol Hypertens23: 592–596, 2014PubMed
LamNN, LentineKL, GargAX: End-stage renal disease risk in live kidney donors: What have we learned from two recent studies?Curr Opin Nephrol Hypertens 23: 592–596, 2014PubMed)| false
MatasAJ, BerglundDM, VockDM, IbrahimHN: Causes and timing of end-stage renal disease after living kidney donation. Am J Transplant18: 1140–1150, 2018PubMed
MatasAJ, BerglundDM, VockDM, IbrahimHN: Causes and timing of end-stage renal disease after living kidney donation. Am J Transplant 18: 1140–1150, 2018PubMed)| false
MassieAB, MuzaaleAD, LuoX, ChowEKH, LockeJE, NguyenAQ, et al.: Quantifying postdonation risk of ESRD in living kidney donors. J Am Soc Nephrol28: 2749–2755, 2017PubMed
MassieAB, MuzaaleAD, LuoX, ChowEKH, LockeJE, NguyenAQ, : Quantifying postdonation risk of ESRD in living kidney donors. J Am Soc Nephrol 28: 2749–2755, 2017PubMed)| false
ReesePP, BloomRD, FeldmanHI, RosenbaumP, WangW, SaynischP, et al.: Mortality and cardiovascular disease among older live kidney donors. Am J Transplant14: 1853–1861, 2014PubMed
ReesePP, BloomRD, FeldmanHI, RosenbaumP, WangW, SaynischP, : Mortality and cardiovascular disease among older live kidney donors. Am J Transplant 14: 1853–1861, 2014PubMed)| false
FuR, SekerciogluN, HishidaM, CoytePC: Economic consequences of adult living kidney donation: A systematic review. Value Health24: 592–601, 2021
FuR, SekerciogluN, HishidaM, CoytePC: Economic consequences of adult living kidney donation: A systematic review. Value Health 24: 592–601, 2021)| false
LentineKL, MannonRB, MandelbrotD: Understanding and overcoming financial risks for living organ donors. Am J Kidney Dis79: 159–161, 2022 34872794
LentineKL, MannonRB, MandelbrotD: Understanding and overcoming financial risks for living organ donors. Am J Kidney Dis 79: 159–161, 2022 34872794)| false
MittelmanM, ThiessenC, ChonWJ, ClayvilleK, CroninDC, FisherJS, et al.: Miscommunicating NOTA can be costly to living donors. Am J Transplant17: 578–580, 2017PubMed
MittelmanM, ThiessenC, ChonWJ, ClayvilleK, CroninDC, FisherJS, : Miscommunicating NOTA can be costly to living donors. Am J Transplant 17: 578–580, 2017PubMed)| false
LentineKL, PastanS, MohanS, ReesePP, LeichtmanA, DelmonicoFL, et al.: A roadmap for innovation to advance transplant access and outcomes: A position statement from the National Kidney Foundation. Am J Kidney Dis78: 319–332, 2021PubMed
LentineKL, PastanS, MohanS, ReesePP, LeichtmanA, DelmonicoFL, : A roadmap for innovation to advance transplant access and outcomes: A position statement from the National Kidney Foundation. Am J Kidney Dis 78: 319–332, 2021PubMed)| false
LentineKL, MannonRB: The Advancing American Kidney Health (AAKH) Executive Order: Promise and caveats for expanding access to kidney transplantation. Kidney3601: 557–560, 2020PubMed
LentineKL, MannonRB: The Advancing American Kidney Health (AAKH) Executive Order: Promise and caveats for expanding access to kidney transplantation. Kidney360 1: 557–560, 2020PubMed)| false
GargN, WatermanAD, RanasingheO, WarnkeL, MorrisJ, CooperM, et al.: Wages, travel, and lodging reimbursement by the National Kidney Registry: An important step toward financial neutrality for living kidney donors in the United States. Transplantation105: 2606–2611, 2021PubMed
GargN, WatermanAD, RanasingheO, WarnkeL, MorrisJ, CooperM, : Wages, travel, and lodging reimbursement by the National Kidney Registry: An important step toward financial neutrality for living kidney donors in the United States. Transplantation 105: 2606–2611, 2021PubMed)| false
FlechnerSM, ThomasAG, RoninM, VealeJL, LeeserDB, KapurS, et al.: The first 9 years of kidney paired donation through the National Kidney Registry: Characteristics of donors and recipients compared with National Live Donor Transplant Registries. Am J Transplant18: 2730–2738, 2018PubMed
FlechnerSM, ThomasAG, RoninM, VealeJL, LeeserDB, KapurS, : The first 9 years of kidney paired donation through the National Kidney Registry: Characteristics of donors and recipients compared with National Live Donor Transplant Registries. Am J Transplant 18: 2730–2738, 2018PubMed)| false
MelcherML, LeeserDB, GritschHA, MilnerJ, KapurS, BusqueS, et al.: Chain transplantation: Initial experience of a large multicenter program. Am J Transplant12: 2429–2436, 2012PubMed
MelcherML, LeeserDB, GritschHA, MilnerJ, KapurS, BusqueS, : Chain transplantation: Initial experience of a large multicenter program. Am J Transplant 12: 2429–2436, 2012PubMed)| false
VealeJL, CapronAM, NassiriN, DanovitchG, GritschHA, WatermanA, et al.: Vouchers for future kidney transplants to overcome “chronological incompatibility” between living donors and recipients. Transplantation101: 2115–2119, 2017PubMed
VealeJL, CapronAM, NassiriN, DanovitchG, GritschHA, WatermanA, : Vouchers for future kidney transplants to overcome “chronological incompatibility” between living donors and recipients. Transplantation 101: 2115–2119, 2017PubMed)| false
CooperM, LeeserDB, FlechnerSM, BeaumontJL, WatermanAD, ShannonPW, et al.: Ensuring the need is met: A 50-year simulation study of the National Kidney Registry’s family voucher program. Am J Transplant21: 1128–1137, 2021PubMed
CooperM, LeeserDB, FlechnerSM, BeaumontJL, WatermanAD, ShannonPW, : Ensuring the need is met: A 50-year simulation study of the National Kidney Registry’s family voucher program. Am J Transplant 21: 1128–1137, 2021PubMed)| false
BasuA, PrietoM, KosbergC, MaiML, KhamashHA, JadlowiecCC, et al.: Ten years of kidney paired donation at Mayo Clinic: The benefits of incorporating ABO/HLA compatible pairs. Transplantation104: 1229–1238, 2020PubMed
BasuA, PrietoM, KosbergC, MaiML, KhamashHA, JadlowiecCC, : Ten years of kidney paired donation at Mayo Clinic: The benefits of incorporating ABO/HLA compatible pairs. Transplantation 104: 1229–1238, 2020PubMed)| false
Lentine KL, Mannon RB, Josephson MA: Practicing with uncertainty: Kidney transplantation during the COVID-19 pandemic. Am J Kidney Dis77: 777–785
93
BoyarskyBJ, Po-Yu ChiangT, WerbelWA, DurandCM, AveryRK, GetsinSN, et al.: Early impact of COVID-19 on transplant center practices and policies in the United States. Am J Transplant20: 1809–1818, 2020PubMed
BoyarskyBJ, Po-Yu ChiangT, WerbelWA, DurandCM, AveryRK, GetsinSN, : Early impact of COVID-19 on transplant center practices and policies in the United States. Am J Transplant 20: 1809–1818, 2020PubMed)| false
SalvalaggioPR, FerreiraGF, CaliskanY, VestLS, SchnitzlerMA, De Sandes-FreitasTV, MouraLR, LamNN, MaldonadoRA, LoupyA, AxelrodDA, LentineKL: An international survey on living kidney donation and transplant practices during the COVID-19 pandemic. Transpl Infect Dis23: e13526, 2021 33245844
SalvalaggioPR, FerreiraGF, CaliskanY, VestLS, SchnitzlerMA, De Sandes-FreitasTV, MouraLR, LamNN, MaldonadoRA, LoupyA, AxelrodDA, LentineKL: An international survey on living kidney donation and transplant practices during the COVID-19 pandemic. Transpl Infect Dis 23: e13526, 2021 33245844)| false
LentineKL, VestLS, SchnitzlerMA, MannonRB, KumarV, DoshiMD, et al.: Survey of US living kidney donation and transplantation practices in the COVID-19 era. Kidney Int Rep5: 1894–1905, 2020PubMed
LentineKL, VestLS, SchnitzlerMA, MannonRB, KumarV, DoshiMD, : Survey of US living kidney donation and transplantation practices in the COVID-19 era. Kidney Int Rep 5: 1894–1905, 2020PubMed)| false
JanMY, JawedAT, BarrosN, AdebiyiO, DiezA, FridellJA, et al.: A national survey of practice patterns for accepting living kidney donors with prior COVID-19. Kidney Int Rep6: 2066–2074, 2021PubMed
JanMY, JawedAT, BarrosN, AdebiyiO, DiezA, FridellJA, : A national survey of practice patterns for accepting living kidney donors with prior COVID-19. Kidney Int Rep 6: 2066–2074, 2021PubMed)| false
KuteVB, FleetwoodVA, MeshramHS, GuenetteA, LentineKL: Use of organs from SARS-cov-2 infected donors: Is it safe? A contemporary review. Curr Transpl Rep8: 281–292, 2021
KuteVB, FleetwoodVA, MeshramHS, GuenetteA, LentineKL: Use of organs from SARS-cov-2 infected donors: Is it safe? A contemporary review. Curr Transpl Rep 8: 281–292, 2021)| false
WeissMJ, LalaniJ, Patriquin-StonerC, DieudéM, HartellD, HornbyL, et al.: Summary of international recommendations for donation and transplantation programs during the coronavirus disease pandemic. Transplantation105: 14–17, 2021PubMed
WeissMJ, LalaniJ, Patriquin-StonerC, DieudéM, HartellD, HornbyL, : Summary of international recommendations for donation and transplantation programs during the coronavirus disease pandemic. Transplantation 105: 14–17, 2021PubMed)| false
